USPTO serial 79133307
G7 THERAPEUTICS
Reviewed by CopyMark Law Group
Reg. 4545756Status 404
- Filing date
- Status date
- Registration date
- Jun 10, 2014
- Examiner
- ELTON, DAVID JONATHAN
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with G7 THERAPEUTICS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemicals for use in industry and science; Biochemical reagents used for non-medical industrial purposes; Biological preparations for use in cell cultures other than for medical or veterinary use, namely, for industrial and scientific purposes; Enzymes derived from biotechnological processes for use in science and industry; Chemical and biochemical reagents, and biological and biotechnological preparations, namely, polypeptides and proteins, all for the development or manufacture of reagents for non-medical industrial and scientific use; Chemicals and biochemical reagents, and biological and biotechnological preparations, namely, polypeptides and proteins, all for non-medical laboratory, diagnostic and analytic industrial and scientific use; Chemicals and biochemical reagents, and biological and biotechnological preparations, namely, polypeptides and proteins, all for use in manufacture of pharmaceuticals | SECTION 71 - CANCELLED | — |
| 005 | Polypeptide, protein, and chemical and biochemical-based pharmaceutical preparations for human and veterinary purposes for the treatment of cancer, central nervous system diseases, inflammation, metabolic diseases, cardiovascular diseases, respiratory diseases, pain, addiction, digestive diseases, reproductive diseases, dermatological diseases | SECTION 71 - CANCELLED | — |
| 042 | Biochemical and diagnostic scientific and technological research services provided by a biochemical or pharmaceutical laboratory in the field of development of pharmaceutical products | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by G7 Therapeutics AG
- Other trademarks owned by Dr. Dirk Tremmel
- Other trademarks owned by Dr. Dirk Tremmel
- Other trademarks owned by Dr. Dirk Tremmel
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 042
- Similar marks named G7 THERAPEUTICS
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jan 1, 2024 | DENC | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED | — |
| Jan 1, 2024 | DETH | DEATH OF INTERNATIONAL REGISTRATION | — |
| Apr 3, 2022 | INNT | TOTAL INVALIDATION PROCESSED BY THE IB | — |
| Feb 24, 2022 | INTS | TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | — |
| Feb 23, 2022 | INPC | INVALIDATION PROCESSED | — |
| Oct 26, 2021 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Feb 26, 2021 | C71T | CANCELLED SECTION 71 | — |
| Jun 10, 2019 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Dec 12, 2014 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Nov 8, 2014 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Nov 8, 2014 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Oct 30, 2014 | CHLD | CHANGE OF OWNER RECEIVED FROM IB | — |
| Oct 28, 2014 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Sep 10, 2014 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jun 10, 2014 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Mar 25, 2014 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Mar 25, 2014 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 21, 2014 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Mar 5, 2014 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Mar 5, 2014 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Mar 5, 2014 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Feb 14, 2014 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Feb 11, 2014 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Feb 10, 2014 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 10, 2014 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 30, 2014 | ALIE | ASSIGNED TO LIE | — |
| Jan 29, 2014 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jan 29, 2014 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 15, 2013 | RFNT | REFUSAL PROCESSED BY IB | — |
| Sep 23, 2013 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Sep 23, 2013 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Sep 21, 2013 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Sep 20, 2013 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 17, 2013 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 6, 2013 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Aug 2, 2013 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Aug 1, 2013 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |